BCX — Bioceltix SA Balance Sheet
0.000.00%
- PLN566.31m
- PLN529.06m
Annual balance sheet for Bioceltix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.1 | 3.2 | 6.05 | 4.12 | 9.31 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.636 | 0.191 | 0.444 | 0.229 | 1.88 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.75 | 3.42 | 6.51 | 4.36 | 11.2 |
Net Property, Plant And Equipment | 0.641 | 1.13 | 1.53 | 1.46 | 1.48 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3.23 | 4.8 | 8.2 | 7.65 | 12.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.32 | 1.33 | 1.91 | 2.25 | 2.14 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.32 | 1.48 | 2.2 | 2.5 | 2.27 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.91 | 3.32 | 6 | 5.15 | 10.5 |
Total Liabilities & Shareholders' Equity | 3.23 | 4.8 | 8.2 | 7.65 | 12.7 |
Total Common Shares Outstanding |